Authors


Kathryn Schlenker, DO

Latest:

Best Communication Practices to Explain Palliative Care Plans

Katie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.


Christine Pham, PharmD

Latest:

Clascoterone cream 1% targets androgen receptors

The topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.


Tracee Blackburn, PA-C

Latest:

Tracee Blackburn, PA-C: Gut Health for Healthy Skin

Blackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.


Sara M. Wilchowski, DMSc, MPAS, PA-C

Latest:

From Clinic to Industry: Insights Into the MSL Role and PA Advocacy

At the 2024 SDPA Fall Conference, Sara Wilchowski, DMSc, MPAS, PA-C, highlighted the challenges and rewards of transitioning to industry roles, the impact of “Insta-Tok” on patient care, and the evolving landscape of dermatology.


Rocco Serrao, MD

Latest:

Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval

We had the chance to catch up with Serrao before he took the stage and he explained why dermatology clinicians should keep their eyes on bimekizumab’s data and shared opportunities for further research.


Nichole Tucker

Latest:

LEAP-010 Study Discontinued for Patients with PD-L1-Expressing HNSCC

A coprimary end point in the phase 3 LEAP-010 study will not be met.


Kennedy Ferruggia

Latest:

Retinoic Acid, Vitamin A Demonstrates Role in Regulating Hair Follicles and Epidermal Stem Cells

In vitro studies demonstrated that retinoic acid aids stem cells in transitioning away from a state of flexibility in wound healing.


Howard Rogers, MD, PhD, FACMS

Latest:

Looking Ahead to the 2023 ACMS Meeting

The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.


Samir Mitragotri, PhD

Latest:

CAGE Bio Advances Skin Disease Treatment

Mitragotri's work bridges advanced drug development and skin care for tailored treatments.



JiaDe 'Jeff' Yu, MD, FAAD

Latest:

Advancing Recognition and Treatment of Allergic Contact Dermatitis

JiaDe Yu, MD, discussed important clinical issues in allergic contact dermatitis at the AAD Annual Meeting.





Christopher G. Bunick, MD, PhD

Latest:

Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care

Discover how the RAD conference in Nashville enhances atopic dermatitis care, featuring expert insights and patient-focused strategies for clinicians.


Brian Iriye, MD

Latest:

Considering consumerism in health care

Patients’ ability to choose can affect your practice.




Steven Dayan, MD, FACS

Latest:

Steven Dayan, MD, FACS: Prioritizing Patient Satisfaction in Cosmetic Dermatology

Steven Dayan, MD, FACS, first author behind a recent study involving high rates of patient satisfaction following treatment with botulinum toxin, discusses the importance of placing patient satisfaction at the forefront of cosmetic dermatology.


Elevate-Derm Conference

Latest:

Elevate-Derm West Conference 2024 Recap

Review insights from a premier dermatology event with expert sessions, hands-on insights, and networking to elevate clinical practice.


Neha Kinariwalla

Latest:

Looking at the scalp and nails during a skin exam is key

A presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.


Dawn Eichenfield, MD, PhD

Latest:

Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

In the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.





Melissa Kanchanapoomi Levin, MD, FAAD

Latest:

Unmasking Botulinum Toxin Myths

Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.


David Cotter, MD, PhD

Latest:

Determining Follow-Up Approach in Melanoma Based on GEP Risk Level

An expert discusses whether the 31-gene expression profile (GEP) risk classification would change treatment guidelines and how the patient’s GEP risk level would influence the approach to surveillance and follow-up.


Amy Spizuoco, DO, FAOCD

Latest:

Getting JAK’d With Amy Spizuoco, DO, FAOCD

The JAK inhibitors have demonstrated efficacy, yet some clinicians are still wary of prescribing them. Amy Spizuoco, DO, FAOCD, shares tips to help clinicians improve their comfort in using them.


Christine Blank

Latest:

Drug Price Hikes Already Found in 2023

List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.


Marcella R. Aquino, MD, FACAAI

Latest:

Marcella R. Aquino, MD, FACAAI: Don’t Make a Rash Dx

Marcella R. Aquino details issues in differential diagnosis for rashes that mimic allergic skin conditions at the ACAAI Annual Meeting.

© 2025 MJH Life Sciences

All rights reserved.